Methylisoindigo and Its bromo-derivatives are selective tyrosine kinase inhibitors, repressing cellular Stat3 activity, and target CD133+ cancer stem cells in PDAC

Indirubin is an active component of the herbal ingredient ‘Danggui Longhui wan’, which was used for the treatment of inflammation and chronic myeloid leukemia in China. The recent study showed its derivative methylisoindigo (also known as meisoindigo) preferentially targeting cancer stem cells (CSCs...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Tegethoff, Jana F. (VerfasserIn) , Bischoff, Roland (VerfasserIn) , Saleh, Sawsan (VerfasserIn) , Blagojević, Biljana (VerfasserIn) , Merz, Karl-Heinz (VerfasserIn) , Cheng, Xinlai (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 13 September 2017
In: Molecules
Year: 2017, Jahrgang: 22, Heft: 9
ISSN:1420-3049
DOI:10.3390/molecules22091546
Online-Zugang:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.3390/molecules22091546
Verlag, kostenfrei, Volltext: http://www.mdpi.com/1420-3049/22/9/1546
Volltext
Verfasserangaben:Jana Tegethoff, Roland Bischoff, Sawsan Saleh, Biljana Blagojevic, Karl-Heinz Merz and Xinlai Cheng

MARC

LEADER 00000caa a2200000 c 4500
001 1566897912
003 DE-627
005 20250612171947.0
007 cr uuu---uuuuu
008 180105s2017 xx |||||o 00| ||eng c
024 7 |a 10.3390/molecules22091546  |2 doi 
035 |a (DE-627)1566897912 
035 |a (DE-576)496897918 
035 |a (DE-599)BSZ496897918 
035 |a (OCoLC)1263950518 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 32  |2 sdnb 
100 1 |a Tegethoff, Jana F.  |d 1995-  |e VerfasserIn  |0 (DE-588)1344374956  |0 (DE-627)1905200943  |4 aut 
245 1 0 |a Methylisoindigo and Its bromo-derivatives are selective tyrosine kinase inhibitors, repressing cellular Stat3 activity, and target CD133+ cancer stem cells in PDAC  |c Jana Tegethoff, Roland Bischoff, Sawsan Saleh, Biljana Blagojevic, Karl-Heinz Merz and Xinlai Cheng 
264 1 |c 13 September 2017 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 05.01.2018 
520 |a Indirubin is an active component of the herbal ingredient ‘Danggui Longhui wan’, which was used for the treatment of inflammation and chronic myeloid leukemia in China. The recent study showed its derivative methylisoindigo (also known as meisoindigo) preferentially targeting cancer stem cells (CSCs) in interference with AMPK and LKB1, the cellular metabolic sensors. In this study, we screened the effect of meisoindigo on a panel of 300 protein kinases and found that it selectively inhibited Stat3-associated tyrosine kinases and further confirmed its activity in cell based assays. To gain a deeper insight into the structure-activity relationship we produced 7 bromo-derivatives exhausting the accessible positions on the bisindole backbone except for in the 4-position due to the space limitation. We compared their anti-proliferative effects on tumor cells. We found that 6-bromomeisoindigo showed improved toxicity in company with increased Stat3 inhibition. Moreover, we detected that 6-bromomeisoindigo induced apoptosis of 95% of CD133+ pancreatic cancer cells. Considering that CD133 is a common marker highly expressed in a range of CSCs, our results imply the potential application of 6-bromomeisoindigo for the treatment of CSCs in different types of cancers. 
650 4 |a cancer stem cells 
650 4 |a indirubin 
650 4 |a meisoindigo 
650 4 |a selective protein kinase inhibitor 
650 4 |a Stat3 inhibitor 
650 4 |a structure-activity-relationship 
650 4 |a TCM 
700 1 |a Bischoff, Roland  |e VerfasserIn  |4 aut 
700 1 |a Saleh, Sawsan  |d 1980-  |e VerfasserIn  |0 (DE-588)1155603400  |0 (DE-627)1017877718  |0 (DE-576)501770186  |4 aut 
700 1 |a Blagojević, Biljana  |d 1990-  |e VerfasserIn  |0 (DE-588)1167446704  |0 (DE-627)1031115854  |0 (DE-576)511149506  |4 aut 
700 1 |a Merz, Karl-Heinz  |d 1951-  |e VerfasserIn  |0 (DE-588)121608735  |0 (DE-627)705570975  |0 (DE-576)292797087  |4 aut 
700 1 |a Cheng, Xinlai  |d 1978-  |e VerfasserIn  |0 (DE-588)140211586  |0 (DE-627)616944179  |0 (DE-576)315074698  |4 aut 
773 0 8 |i Enthalten in  |t Molecules  |d Basel : MDPI, 1996  |g 22(2017,9) Artikel-Nummer 1546, 16 Seiten  |h Online-Ressource  |w (DE-627)311313132  |w (DE-600)2008644-1  |w (DE-576)281192456  |x 1420-3049  |7 nnas  |a Methylisoindigo and Its bromo-derivatives are selective tyrosine kinase inhibitors, repressing cellular Stat3 activity, and target CD133+ cancer stem cells in PDAC 
773 1 8 |g volume:22  |g year:2017  |g number:9  |a Methylisoindigo and Its bromo-derivatives are selective tyrosine kinase inhibitors, repressing cellular Stat3 activity, and target CD133+ cancer stem cells in PDAC 
856 4 0 |u http://dx.doi.org/10.3390/molecules22091546  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://www.mdpi.com/1420-3049/22/9/1546  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20180105 
993 |a Article 
994 |a 2017 
998 |g 140211586  |a Cheng, Xinlai  |m 140211586:Cheng, Xinlai  |d 160000  |d 160100  |e 160000PC140211586  |e 160100PC140211586  |k 0/160000/  |k 1/160000/160100/  |p 6  |y j 
998 |g 1167446704  |a Blagojević, Biljana  |m 1167446704:Blagojević, Biljana  |d 140000  |e 140000PB1167446704  |k 0/140000/  |p 4 
998 |g 1155603400  |a Saleh, Sawsan  |m 1155603400:Saleh, Sawsan  |d 140000  |e 140000PS1155603400  |k 0/140000/  |p 3 
998 |g 1344374956  |a Tegethoff, Jana F.  |m 1344374956:Tegethoff, Jana F.  |d 140000  |e 140000PT1344374956  |k 0/140000/  |p 1  |x j 
999 |a KXP-PPN1566897912  |e 2991706635 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Jana Tegethoff, Roland Bischoff, Sawsan Saleh, Biljana Blagojevic, Karl-Heinz Merz and Xinlai Cheng"]},"person":[{"given":"Jana F.","family":"Tegethoff","role":"aut","roleDisplay":"VerfasserIn","display":"Tegethoff, Jana F."},{"given":"Roland","family":"Bischoff","role":"aut","display":"Bischoff, Roland","roleDisplay":"VerfasserIn"},{"display":"Saleh, Sawsan","roleDisplay":"VerfasserIn","role":"aut","family":"Saleh","given":"Sawsan"},{"given":"Biljana","family":"Blagojević","role":"aut","roleDisplay":"VerfasserIn","display":"Blagojević, Biljana"},{"family":"Merz","given":"Karl-Heinz","roleDisplay":"VerfasserIn","display":"Merz, Karl-Heinz","role":"aut"},{"given":"Xinlai","family":"Cheng","role":"aut","display":"Cheng, Xinlai","roleDisplay":"VerfasserIn"}],"origin":[{"dateIssuedKey":"2017","dateIssuedDisp":"13 September 2017"}],"title":[{"title_sort":"Methylisoindigo and Its bromo-derivatives are selective tyrosine kinase inhibitors, repressing cellular Stat3 activity, and target CD133+ cancer stem cells in PDAC","title":"Methylisoindigo and Its bromo-derivatives are selective tyrosine kinase inhibitors, repressing cellular Stat3 activity, and target CD133+ cancer stem cells in PDAC"}],"id":{"doi":["10.3390/molecules22091546"],"eki":["1566897912"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 05.01.2018"],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2008644-1"],"eki":["311313132"],"issn":["1420-3049"]},"origin":[{"dateIssuedDisp":"1996-","dateIssuedKey":"1996","publisher":"MDPI","publisherPlace":"Basel"}],"name":{"displayForm":["Molecular Diversity Preservation International"]},"part":{"text":"22(2017,9) Artikel-Nummer 1546, 16 Seiten","volume":"22","issue":"9","year":"2017"},"pubHistory":["1.1996 -"],"language":["eng"],"recId":"311313132","note":["Gesehen am 25.06.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Methylisoindigo and Its bromo-derivatives are selective tyrosine kinase inhibitors, repressing cellular Stat3 activity, and target CD133+ cancer stem cells in PDACMolecules","title":[{"title_sort":"Molecules","subtitle":"a journal of synthetic chemistry and natural product chemistry","title":"Molecules"}]}],"language":["eng"],"recId":"1566897912"} 
SRT |a TEGETHOFFJMETHYLISOI1320